{
  "error": false,
  "count": 2,
  "total_hits": 35,
  "patents": [
    {
      "patent_id": "10995231",
      "patent_title": "Lipid nanoparticle compositions for nucleic acid delivery",
      "patent_abstract": "Compositions include ionizable lipids, helper lipids, PEG-lipids, and targeting moieties for liver-directed delivery.",
      "patent_date": "2021-05-04",
      "application": {"filing_date": "2017-09-12"},
      "assignees": [{"assignee_organization": "ModernaTX, Inc."}],
      "cpc_at_issue": [{"cpc_subclass_id": "A61K"}, {"cpc_subclass_id": "C12N"}],
      "inventors": [{"inventor_name_first": "Sara", "inventor_name_last": "Kim"}]
    },
    {
      "patent_id": "10869944",
      "patent_title": "Targeted mRNA formulations for metabolic disease",
      "patent_abstract": "Disclosed are mRNA delivery particles with receptor-targeting ligands and controlled particle size.",
      "patent_date": "2020-12-22",
      "application": {"filing_date": "2016-11-07"},
      "assignees": [{"assignee_organization": "Regeneron Pharmaceuticals, Inc."}],
      "cpc_at_issue": [{"cpc_subclass_id": "A61K"}],
      "inventors": [{"inventor_name_first": "Dina", "inventor_name_last": "Park"}]
    }
  ]
}
